EUVIMEDEUVIMED entdecken
Crossref

Comparative insights into gut microbiota, diet, and inflammation in Inflammatory Bowel Diseases and canine enteropathy

Miljana Glazar, Sonia Facchin

Academia Nutrition and Dietetics · 2025

DOI: 10.20935/acadnutr7951 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Academia Nutrition and Dietetics, 2025. Verfasst von Miljana Glazar und 1 weiteren Autor:innen. Die Arbeit nennt 235 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Inflammatory Bowel Diseases (IBD) in humans and Canine Chronic Enteropathies (CCE) are chronic conditions marked by intestinal inflammation. Despite different clinical management, both share genetic predisposition, microbiota dysbiosis, and environmental triggers.

Objective

To compare IBD and CCE, focusing on diet, gut microbiota, and fecal microbiota transplantation (FMT) as emerging therapies. Materials and methods: A narrative review was conducted using PubMed, Scopus, and Science Direct, emphasizing studies from the past 10 years. Evidence on pathogenesis, treatments, dietary strategies, and FMT in both species was analyzed.

Results

In humans, pharmacological therapy is standard, while in dogs, diet is the first-line treatment. Dysbiosis plays a significant role in both, affecting inflammation and disease progression. Nutritional strategies impact microbiota composition; fiber promotes beneficial taxa and short-chain fatty acids, while high-protein or high-fat diets may worsen dysbiosis. FMT is effective for recurrent Clostridioides difficile infection in humans and is increasingly explored in IBD, especially ulcerative colitis. In dogs, preliminary studies suggest FMT can improve clinical signs and microbiota balance, though responses vary.

Discussion

IBD and CCE share fundamental mechanisms but exhibit species-specific differences. Diet and FMT are promising, non-invasive, and sustainable options.

Conclusions

Comparative research and the One Health approach, which highlights shared environmental and biological determinants between humans and animals, could facilitate the development of precision therapies for chronic intestinal inflammation. Therefore, the proper planning of translational studies is crucial.

Zitieren

APA

Glazar, M., & Facchin, S. (2025). Comparative insights into gut microbiota, diet, and inflammation in Inflammatory Bowel Diseases and canine enteropathy. Academia Nutrition and Dietetics. https://doi.org/10.20935/acadnutr7951

Vancouver

Glazar M, Facchin S. Comparative insights into gut microbiota, diet, and inflammation in Inflammatory Bowel Diseases and canine enteropathy. Academia Nutrition and Dietetics. 2025. doi:10.20935/acadnutr7951

BibTeX
@article{Glazar2025,
  author = {Glazar, Miljana and Facchin, Sonia},
  title = {Comparative insights into gut microbiota, diet, and inflammation in Inflammatory Bowel Diseases and canine enteropathy},
  journal = {Academia Nutrition and Dietetics},
  year = {2025},
  doi = {10.20935/acadnutr7951}
}
Kostenlos starten →